High Tide, Inc. Q3 FY2026 earnings call

• Record Financials: Q3 was described as the best quarter in company history, with revenue hitting a record $198.8 million (up 33% YoY) and net income reaching $12.7 million. Adjusted EBITDA was $16.2 million (up 52% YoY).

• Operational Leverage: Significant cost control measures led to trailing salaries and wages dropping to 11.4% of revenue and G&A to 3.9%, both all-time lows. Gross profit dollars grew 2.5 times faster than operating expenses.

• Free Cash Flow & Balance Sheet: Generated $7 million in free cash flow and $11.9 million in operating cash flow before working capital changes. The balance sheet remains strong with no meaningful debt maturities for three years and $25 million available on a Bank of Montreal revolver.

• Market Leadership in Canada: High Tide maintains its position as the preeminent brand with 232 stores. Average store revenue run rates are significantly higher than peers ($2.6 million vs. $1.4 million peer average). Market share in key provinces is rising toward a 15% milestone.

• Growth in Germany: Ramexian is scaling rapidly with volumes exceeding expectations. Management believes Canadian medical cannabis exports to Germany are approaching a $600 million annual run rate, providing ample room for further volume growth.

• Strategic Discipline: Management emphasized a 'no rush' approach to international expansion (e.g., UK), prioritizing organic growth in Canada and Germany first. They remain open to acquisitions but will not compromise on price or timing for shareholder value.

The company reported record financial performance across both primary segments for the quarter ended July 31, 2026.

• Brick-and-Mortar (Canada): Revenue grew 9% sequentially and 33% year-over-year. This segment maintained a gross margin of 27% and contributed significantly to the consolidated adjusted EBITDA growth of 11% year-over-year. Same-store sales were flat for the full quarter but showed positive momentum in June and July, with transaction counts up 1.1%. The segment benefits from a loyalty program with 2.73 million Cabana Club members and 186,000 paid Elite members.

• Medical Cannabis Distribution (Germany/Ramexian): Revenue reached $38.2 million, up 21% sequentially and 165% higher than the pace at transaction close one year ago. Adjusted EBITDA rose 38% sequentially to $4.4 million, achieving a record 12% margin. Sales volume increased to 10.2 tons. The segment holds an estimated market share of 10.5% in Germany.

• Forward-Looking Confidence: Management expressed high confidence in continued bottom-line growth, noting that adjusted net income has ramped significantly.

• Revenue Milestone: Confident in breaching the $1 billion revenue mark in the near future, driven by the combination of Canadian store expansion (targeting 350 locations long-term) and German volume scaling.

• Margin Trajectory: Expects consolidated gross margins to remain in the mid-to-high 20s. Specifically, Ramexian’s gross margins are expected to stabilize in the mid-to-high 20s despite some price compression in the German market, supported by superior procurement costs.

• Store Expansion: Reiterated the goal of adding 20 stores in the current calendar year and maintaining a long-term target of 350 locations in Canada.

• Macroeconomic Uncertainty: Consumer spending is under pressure due to inflation and job stress, leading to thinner shopping baskets (customers buying less per visit), although transaction counts remain stable.

• Competitive Dynamics: Increased competition in Canada, with store counts rising 5% in Ontario and Alberta over the past 12 months. Smaller operators may face consolidation or exit, creating market disruption.

• Regulatory/Quota Issues in Germany: Import quotas can act as short-term constraints on volume ramp-up, though management views this as manageable and not a long-term issue.

• Market Share Volatility: Industry data restatements (e.g., by Bee Farm) can impact calculated market share figures, requiring careful monitoring of actual vs. reported industry trends.

Q: Analyst asked about potential impacts of import quota fluctuations in Germany similar to last year and whether current gross margins represent a normalized level. / A: Raj Grover stated that while import quotas can cause short-term inventory clearance issues, they are not a long-term concern given the surging demand for Canadian cannabis in Germany. He confirmed that gross margins have stabilized around 26-27%, which he considers a strong, sustainable trajectory despite broader price compression in the German market, attributing this to Hightide's superior procurement power as a large-scale buyer.

Q: Analyst inquired about consumer habits amid economic stress and how August same-store sales compare to previous quarters. / A: Raj Grover explained that while consumers are building thinner baskets due to inflationary pressures, transaction counts have remained positive (up 1.1% in Q3 and continuing into August). This indicates customer retention and market share gains rather than loss. He noted that once consumer financial conditions improve, spending per visit is expected to increase, but currently, the focus is on maintaining traffic through their dominant discount club model.

Q: Analyst asked if capacity constraints would limit Ramexian's ability to maintain its rapid growth pace in Germany. / A: Raj Grover affirmed there is significant room for growth, citing exponential tonnage increases from 7.6 tons in Q2 to 10.2 tons in Q3. He expressed confidence in continuing to ramp volumes and targeting a long-term market share of 15-20% in Germany, leveraging their unique position as a free-agent distributor without competing directly with local licensees.

Q: Analyst questioned the rationale for factoring receivables in Germany, the interest rates involved, and whether this practice will continue. / A: Raj Grover clarified that factoring in Germany is highly efficient, with interest rates around 9% compared to 17-20% in North America, due to the creditworthiness of pharmacy buyers. He confirmed that Hightide is actively expanding its use of factoring to support growth and sees no issues with creditworthiness or availability, viewing it as a strategic advantage inherited from Remaxian’s prior relationships.

Q: Analyst sought details on the drivers behind the recent positive same-store sales inflection in Canada, specifically regarding loyalty programs and customer behavior. / A: Raj Grover attributed the turnaround primarily to the strength of the Cabana Club loyalty model and the paid Elite membership tier. He highlighted that paid members exhibit higher loyalty, larger basket sizes, and greater shopping frequency. Combined with prime location strategy and white-label initiatives, these factors allow Hightide to outperform competitors who are experiencing negative same-store sales.